Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human monoclonal antibody to human interleukin (IL)-17A of the IgG1/k class

EU orphan designation number: EU/3/09/724   
Active ingredient: Recombinant human monoclonal antibody to human interleukin (IL)-17A of the IgG1/k class
Indication: Treatment of chronic non-infectious uveitis
Sponsor: Novartis Europharm Limited
Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
04/02/2010 Centralised Orphan - Designation EMEA/OD/060/09 (2010)787 of 02/02/2010